Show simple item record

dc.contributor.authorReed, Darren
dc.date.accessioned2025-02-03T16:27:20Z
dc.date.available2025-02-03T16:27:20Z
dc.date.issued2024-09
dc.identifier.citationKiran, S., Mavilakandy, A., Rahim, S., Naeem, M., Rawson, S., Reed, D., Tsaknis, G., & Reddy, R. V. (2024). The role of day-case thoracoscopy at a district general hospital: A real world observational study. Future healthcare journal v11(3) article: 100158. https://doi.org/10.1016/j.fhj.2024.100158en_US
dc.identifier.otherhttps://doi.org/10.1016/j.fhj.2024.100158
dc.identifier.urihttp://hdl.handle.net/20.500.12904/19225
dc.description.abstractObjective To assess the feasibility and safety of talc pleurodesis performed as part of day-case medical thoracoscopy. Methods A Richard Wolf® 5 mm mini thoracoscope through a 5.5 mm port was used with eligible cases having talc poudrage followed by insertion of indwelling pleural catheter (IPC). District nurses drain the IPC daily for the first 5 days. Once the drain output is <150 mL, the frequency is progressively reduced to once weekly. The drain is removed after two consecutive dry taps 1 week apart. Results Overall, 51 patients underwent day-case thoracoscopy. Median time to removal of IPC for our day-case protocol was 14 days. There were seven deaths within 70 days among 41 patients with malignant pleural effusion in the day-case cohort, compared to eight deaths in the 33 conventional thoracoscopy controls. Overall, the day-case cohort observed a statistically significant reduction in all-cause mortality at 180 days compared to the conventional cohort (log rank p = 0.024). The average cost per patient of the day-case and inpatient cohort was £1,328.0 ± 106.0 and £1,835.0 ± 295.0 (p = 0.961). Conclusion This study suggests that thoracoscopy and talc poudrage can be performed safely as a day-case procedure. Further data are needed to ascertain long-term outcomes.
dc.description.urihttps://www.sciencedirect.com/science/article/pii/S2514664524015480?via%3Dihuben_US
dc.language.isoenen_US
dc.titleThe role of day-case thoracoscopy at a district general hospital: A real world observational studyen_US
dc.typeArticleen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionNAen_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.panelUnspecifieden_US
refterms.dateFirstOnline2024-09-13
html.description.abstractObjective To assess the feasibility and safety of talc pleurodesis performed as part of day-case medical thoracoscopy. Methods A Richard Wolf® 5 mm mini thoracoscope through a 5.5 mm port was used with eligible cases having talc poudrage followed by insertion of indwelling pleural catheter (IPC). District nurses drain the IPC daily for the first 5 days. Once the drain output is <150 mL, the frequency is progressively reduced to once weekly. The drain is removed after two consecutive dry taps 1 week apart. Results Overall, 51 patients underwent day-case thoracoscopy. Median time to removal of IPC for our day-case protocol was 14 days. There were seven deaths within 70 days among 41 patients with malignant pleural effusion in the day-case cohort, compared to eight deaths in the 33 conventional thoracoscopy controls. Overall, the day-case cohort observed a statistically significant reduction in all-cause mortality at 180 days compared to the conventional cohort (log rank p = 0.024). The average cost per patient of the day-case and inpatient cohort was £1,328.0 ± 106.0 and £1,835.0 ± 295.0 (p = 0.961). Conclusion This study suggests that thoracoscopy and talc poudrage can be performed safely as a day-case procedure. Further data are needed to ascertain long-term outcomes.en_US
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


This item appears in the following Collection(s)

Show simple item record